JCMAX
Price
$61.37
Change
-$0.81 (-1.30%)
Updated
Jun 13 closing price
Net Assets
5.33B
VMCPX
Price
$365.78
Change
-$4.27 (-1.15%)
Updated
Jun 13 closing price
Net Assets
185.28B
Interact to see
Advertisement

JCMAX vs VMCPX

Header iconJCMAX vs VMCPX Comparison
Open Charts JCMAX vs VMCPXBanner chart's image
JPMorgan Mid Cap Equity A
Price$61.37
Change-$0.81 (-1.30%)
VolumeN/A
Net Assets5.33B
Vanguard Mid Cap Index InstitutionalPlus
Price$365.78
Change-$4.27 (-1.15%)
VolumeN/A
Net Assets185.28B
JCMAX vs VMCPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCMAX vs. VMCPX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCMAX is a Buy and VMCPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 185B vs. JCMAX (5.34B). VMCPX pays higher dividends than JCMAX: VMCPX (1.54) vs JCMAX (0.23). JCMAX was incepted earlier than VMCPX: JCMAX (16 years) vs VMCPX (15 years). JCMAX (1.20) is less costly to investors than VMCPX (0.03). JCMAX is a more actively managed with annual turnover of: 38.00 vs. VMCPX (16.00). JCMAX has a lower initial minimum investment than VMCPX: JCMAX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 11.60 vs. JCMAX (3.65). VMCPX return over 5 years is better than : 69.72 vs. JCMAX (33.96).
JCMAXVMCPXJCMAX / VMCPX
Total Expense Ratio1.090.033,633%
Annual Report Gross Expense Ratio1.200.034,000%
Fund Existence16 years15 years-
Gain YTD-0.9042.781-33%
Front Load5%N/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.34B185B3%
Annual Yield % from dividends0.231.5415%
Returns for 1 year3.6511.6031%
Returns for 3 years28.6139.1673%
Returns for 5 years33.9669.7249%
Returns for 10 years30.84114.2627%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCC21.53-0.27
-1.24%
Ares Capital Corp
ATMU35.25-1.09
-3.00%
Atmus Filtration Technologies
TSHA2.54-0.11
-4.15%
Taysha Gene Therapies
LTRX2.34-0.12
-4.88%
Lantronix
MBIO1.17-0.10
-7.87%
Mustang Bio Inc